Taiyen Biotech Co., Ltd. (TPE:1737)

Taiyen Biotech Revenue

Taiyen Biotech had revenue of 789.50M TWD in the quarter ending March 31, 2026, a decrease of -3.62%. This brings the company's revenue in the last twelve months to 3.28B, up 1.05% year-over-year. In the year 2025, Taiyen Biotech had annual revenue of 3.31B with 2.15% growth.

• Revenue (ttm): 3.28B
• Revenue Growth: +1.05%
• P/S Ratio: 1.92
• Revenue / Employee: 7.28M
• Employees: 487
• Market Cap: 6.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.31B	69.51M	2.15%
Dec 31, 2024	3.24B	-170.66M	-5.01%
Dec 31, 2023	3.41B	-204.80M	-5.67%
Dec 31, 2022	3.61B	-482.04M	-11.77%
Dec 31, 2021	4.10B	965.30M	30.84%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error